Background. Hepatocellular carcinoma (HCC) is a common, difficult to treat cancer. Current treatment are surgical resection and liver transplantation. Inpatients who are unsuitable candidates for ...surgery, local ablation therapiesappear to be valid mainly for treatment of single neoplastic lesions smaller than 3-4 cm in diameter. Systemic chemotherapy is mostly inactive. Thedual vascular supply of the liver affords a unique opportunity to explore intraarterial therapies for hepatocellular carcinoma. Chemoembolization is a well-established technique combining intraarterial chemotherapy (mytomicin) with Lipiodol and delivery of embolic agents (Ivalon, Biospherej. In this article authors describe the role of chemoembolization (TACE) in the management of HCC. A clear presentation of TACE indications and contraindications is given. A detailed description of the procedure, complications, therapeutic results and a postprocedure follow-up are given.
It was not necessary to add the material to the shelf.
Bibliographic material was successfully added on shelf.
Adding bibliographical material on shelf was not successful.
Material is already on the shelf.
Permalink
URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year
Impact factor
Edition
Category
Classification
JCR
SNIP
JCR
SNIP
JCR
SNIP
JCR
SNIP
Select the library membership card:
DRS,
in which the journal is indexed
Database name
Field
Year
Links to authors' personal bibliographies
Links to information on researchers in the SICRIS system
Subject headings in COBISS General List of Subject Headings
Select pickup location
The material from the parent unit is free. If the material is delivered to the pickup location from another unit, the library may charge you for this service.
